These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 21545364

  • 1. Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators.
    Steven D, Roberts-Thomson KC, Inada K, Seiler J, Koplan BA, Tedrow UB, Sweeney MO, Epstein LE, Stevenson WG.
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1115-9. PubMed ID: 21545364
    [Abstract] [Full Text] [Related]

  • 2. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.
    Kim SH, Nam GB, Baek S, Choi HO, Kim KH, Choi KJ, Joung B, Pak HN, Lee MH, Kim SS, Park SJ, On YK, Kim JS, Oh IY, Choi EK, Oh S, Choi YS, Choi JI, Park SW, Kim YH, Lee MY, Lim HE, Lee YS, Cho Y, Kim J, Lee DI, Cho DK, Kim YH.
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):757-63. PubMed ID: 22353358
    [Abstract] [Full Text] [Related]

  • 3. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Gepner K, Pytkowski M, Kowalik I, Maczyńska-Mazuruk R, Ruzyłło W, Szwed H.
    J Cardiovasc Electrophysiol; 2010 Aug 01; 21(8):883-9. PubMed ID: 20132378
    [Abstract] [Full Text] [Related]

  • 4. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S, Shetboun I, Khalamizer V, Fuchs T, Boulos M, Geist M, Strasberg B, Ilan M, Belhassen B, Israeli Working Group on Cardiac Pacing and Electrophysiology.
    Isr Med Assoc J; 2008 Jun 01; 10(6):435-9. PubMed ID: 18669142
    [Abstract] [Full Text] [Related]

  • 5. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
    Olde Nordkamp LR, Wilde AA, Tijssen JG, Knops RE, van Dessel PF, de Groot JR.
    Circ Arrhythm Electrophysiol; 2013 Feb 01; 6(1):91-100. PubMed ID: 23275262
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.
    Sarkozy A, Boussy T, Kourgiannides G, Chierchia GB, Richter S, De Potter T, Geelen P, Wellens F, Spreeuwenberg MD, Brugada P.
    Eur Heart J; 2007 Feb 01; 28(3):334-44. PubMed ID: 17251258
    [Abstract] [Full Text] [Related]

  • 7. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F, Probst V, Maury P, Babuty D, Mansourati J, Komatsu Y, Marquie C, Rosa A, Diallo A, Cassagneau R, Loizeau C, Martins R, Field ME, Derval N, Miyazaki S, Denis A, Nogami A, Ritter P, Gourraud JB, Ploux S, Rollin A, Zemmoura A, Lamaison D, Bordachar P, Pierre B, Jaïs P, Pasquié JL, Hocini M, Legal F, Defaye P, Boveda S, Iesaka Y, Mabo P, Haïssaguerre M.
    Circulation; 2013 Oct 15; 128(16):1739-47. PubMed ID: 23995538
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB, Della Rocca DG, Papavasileiou LP, Panattoni G, Sergi D, Duro L, Mahfouz K, Magliano G, Santini L, Romeo F.
    J Cardiovasc Med (Hagerstown); 2011 Nov 15; 12(11):779-84. PubMed ID: 21941203
    [Abstract] [Full Text] [Related]

  • 9. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
    Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, Giordano U, Pappone C, Mascioli G, Rossetti G, De Nardis R, Colombo M.
    J Am Coll Cardiol; 2012 Jan 03; 59(1):37-45. PubMed ID: 22192666
    [Abstract] [Full Text] [Related]

  • 10. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, La Meir M, Wellens F, Czapla J, Wauters K, Levinstein M, Saitoh Y, Irfan G, Julià J, Pappaert G, Brugada P.
    J Am Coll Cardiol; 2015 Mar 10; 65(9):879-88. PubMed ID: 25744005
    [Abstract] [Full Text] [Related]

  • 11. Long-term complications of implantable defibrillator therapy in Brugada syndrome.
    Miyazaki S, Uchiyama T, Komatsu Y, Taniguchi H, Kusa S, Nakamura H, Hachiya H, Isobe M, Hirao K, Iesaka Y.
    Am J Cardiol; 2013 May 15; 111(10):1448-51. PubMed ID: 23433764
    [Abstract] [Full Text] [Related]

  • 12. Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    Gonzalez Corcia MC, Sieira J, Pappaert G, de Asmundis C, Chierchia GB, La Meir M, Sarkozy A, Brugada P.
    J Am Coll Cardiol; 2018 Jan 16; 71(2):148-157. PubMed ID: 29325638
    [Abstract] [Full Text] [Related]

  • 13. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry.
    Daoulah A, Alsheikh-Ali AA, Ocheltree AH, Ocheltree S, Al-Kaabi S, Malik M, Al-Habib AK, Hamed A, Al-Rawahi N, Al-Sayegh A, Al-Hasaniah S, Ul-Haq E.
    J Electrocardiol; 2012 Jan 16; 45(3):327-32. PubMed ID: 22074744
    [Abstract] [Full Text] [Related]

  • 14. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy.
    DeWitt ES, Triedman JK, Cecchin F, Mah DY, Abrams DJ, Walsh EP, Gauvreau K, Alexander ME.
    Circ Arrhythm Electrophysiol; 2014 Dec 16; 7(6):1057-63. PubMed ID: 25262116
    [Abstract] [Full Text] [Related]

  • 15. An unusual case of Brugada syndrome in a 10-year-old child with fevers.
    Zaidi AN.
    Congenit Heart Dis; 2010 Dec 16; 5(6):594-8. PubMed ID: 21106020
    [Abstract] [Full Text] [Related]

  • 16. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.
    Barsheshet A, Goldenberg I, Moss AJ, Huang DT, Zareba W, McNitt S, Klein HU, Guetta V.
    J Cardiovasc Electrophysiol; 2011 Nov 16; 22(11):1237-42. PubMed ID: 21615813
    [Abstract] [Full Text] [Related]

  • 17. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R, Sapp JL, Basta M, Doucette S, Thompson K, Gardner M, Gray C, Brownell B, Kidwai H, Cox J.
    Circ Arrhythm Electrophysiol; 2012 Aug 01; 5(4):706-13. PubMed ID: 22685111
    [Abstract] [Full Text] [Related]

  • 18. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.
    Heart; 2009 May 01; 95(9):709-14. PubMed ID: 19282314
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA.
    Europace; 2013 Mar 01; 15(3):347-54. PubMed ID: 23002195
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome.
    Kamakura T, Wada M, Nakajima I, Ishibashi K, Miyamoto K, Okamura H, Noda T, Aiba T, Takaki H, Yasuda S, Ogawa H, Shimizu W, Makiyama T, Kimura T, Kamakura S, Kusano K.
    Circ Arrhythm Electrophysiol; 2015 Aug 01; 8(4):785-91. PubMed ID: 26067668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.